ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 924,50
1,02%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. DelMar Pharmaceuticals Inc (DMPI)

  7. DelMar Pharmaceuticals Inc (DMPI) Actualités

DMPI

DelMar Pharmaceuticals (DMPI)

DelMar Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DMPI
DateHeureSourceTitreSymboleSociété
15/06/202321h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMPIDelMar Pharmaceuticals Inc
11/05/202314h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DMPIDelMar Pharmaceuticals Inc
31/03/202322h17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
31/03/202322h15Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DMPIDelMar Pharmaceuticals Inc
13/02/202322h30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
27/09/202222h37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DMPIDelMar Pharmaceuticals Inc
27/09/202214h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DMPIDelMar Pharmaceuticals Inc
03/08/202222h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMPIDelMar Pharmaceuticals Inc
03/08/202215h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DMPIDelMar Pharmaceuticals Inc
06/05/202222h12Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
26/04/202222h17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
03/05/202122h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DMPIDelMar Pharmaceuticals Inc
02/04/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DMPIDelMar Pharmaceuticals Inc
24/03/202122h03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:DMPIDelMar Pharmaceuticals Inc
16/11/202020h38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMPIDelMar Pharmaceuticals Inc
04/11/202022h45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:DMPIDelMar Pharmaceuticals Inc
25/09/202001h29Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
28/08/202016h50Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DMPIDelMar Pharmaceuticals Inc
18/08/202014h30PR Newswire (US)DelMar Announces $19.6 Million Private Placement Priced At-The-MarketNASDAQ:DMPIDelMar Pharmaceuticals Inc
17/08/202014h30PR Newswire (US)DelMar Announces Approval of Merger by StockholdersNASDAQ:DMPIDelMar Pharmaceuticals Inc
17/07/202014h00PR Newswire (US)DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero PharmaceuticalsNASDAQ:DMPIDelMar Pharmaceuticals Inc
02/07/202023h31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DMPIDelMar Pharmaceuticals Inc
24/06/202014h30PR Newswire (US)DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Resear...NASDAQ:DMPIDelMar Pharmaceuticals Inc
22/06/202014h30PR Newswire (US)DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed an...NASDAQ:DMPIDelMar Pharmaceuticals Inc
16/06/202023h12Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:DMPIDelMar Pharmaceuticals Inc
10/06/202014h30PR Newswire (US)DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology PipelineNASDAQ:DMPIDelMar Pharmaceuticals Inc
04/06/202014h00PR Newswire (US)Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal...NASDAQ:DMPIDelMar Pharmaceuticals Inc
01/06/202014h00PR Newswire (US)DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Canc...NASDAQ:DMPIDelMar Pharmaceuticals Inc
13/05/202014h00PR Newswire (US)DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate UpdatesNASDAQ:DMPIDelMar Pharmaceuticals Inc
05/05/202014h00PR Newswire (US)DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment o...NASDAQ:DMPIDelMar Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DMPI

Dernières Valeurs Consultées

TSX
CRP
Ceres Global
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés